A Comprehensive Approach on Post Operative Nausea and Vomiting (PONV)
Since 2021, HOI has developed a comprehensive approach to preventing and treating post-operative nausea and vomiting (PONV). These performance improvement initiatives have had a positive impact on patient care and outcomes.
HOI’s work on PONV started with patient education and continues to be a focus for performance improvement. We review our patient comments and look for best practices and new modalities to prevent and/or reduce PONV. For some of our patients, PONV is worse than the pain from their surgery.
HOI uses current research to help identify risk factors and to develop an evidence-based program to prevent and manage PONV. Through extensive data collection and clinical review, HOI began to implement a preoperative hydration protocol for patients without contraindications. Now, those patients are encouraged to drink 16 ounces of carb-loaded drinks, two hours prior to arriving at the hospital for surgery.
Patients who have a history of moderate to severe PONV are now provided prophylactic treatment with Aprepitant as well as traditional medications such as Zofran and Decadron to help reduce PONV. We incorporated the use of Barhemsys as a rescue medication. We found that 78 percent of our patients had a reduction in PONV severity after administering medication.
We continue to provide patient education to all patients through our educational platforms on what to do prior and after surgery to prevent or handle PONV.
Given the higher incidence of postoperative nausea and vomiting (PONV) among female patients, our protocols incorporate risk stratification and targeted prophylactic interventions to reduce the likelihood of PONV.


